These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 19324982

  • 1. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder.
    Bonnan M, Valentino R, Olindo S, Mehdaoui H, Smadja D, Cabre P.
    Mult Scler; 2009 Apr; 15(4):487-92. PubMed ID: 19324982
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ.
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The rescue effect of plasma exchange for neuromyelitis optica.
    Wang KC, Wang SJ, Lee CL, Chen SY, Tsai CP.
    J Clin Neurosci; 2011 Jan; 18(1):43-6. PubMed ID: 20888238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Severe bouts of neuromyelitis optica: dramatic improvement after plasma exchanges].
    Bonnan M, Brasme H, Diaby MM, Vlaicu M, Le Guern V, Zuber M.
    Rev Neurol (Paris); 2009 May; 165(5):479-81. PubMed ID: 18848342
    [Abstract] [Full Text] [Related]

  • 10. Idiopathic severe recurrent transverse myelitis: a restricted variant of neuromyelitis optica.
    Chan KH, Tsang KL, Fong GC, Cheung RT, Ho SL.
    Clin Neurol Neurosurg; 2005 Feb; 107(2):132-5. PubMed ID: 15708229
    [Abstract] [Full Text] [Related]

  • 11. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.
    Jacob A, Weinshenker BG, Violich I, McLinskey N, Krupp L, Fox RJ, Wingerchuk DM, Boggild M, Constantinescu CS, Miller A, De Angelis T, Matiello M, Cree BA.
    Arch Neurol; 2008 Nov; 65(11):1443-8. PubMed ID: 18779415
    [Abstract] [Full Text] [Related]

  • 12. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
    Hamnik SE, Hacein-Bey L, Biller J, Gruener G, Jay W.
    Semin Ophthalmol; 2008 Nov; 23(3):191-200. PubMed ID: 18432545
    [Abstract] [Full Text] [Related]

  • 13. Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders.
    Lim YM, Pyun SY, Kang BH, Kim J, Kim KK.
    Mult Scler; 2013 Aug; 19(9):1216-8. PubMed ID: 23263897
    [Abstract] [Full Text] [Related]

  • 14. Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica.
    Costanzi C, Matiello M, Lucchinetti CF, Weinshenker BG, Pittock SJ, Mandrekar J, Thapa P, McKeon A.
    Neurology; 2011 Aug 16; 77(7):659-66. PubMed ID: 21813788
    [Abstract] [Full Text] [Related]

  • 15. Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders.
    Bonnan M, Valentino R, Debeugny S, Merle H, Fergé JL, Mehdaoui H, Cabre P.
    J Neurol Neurosurg Psychiatry; 2018 Apr 16; 89(4):346-351. PubMed ID: 29030418
    [Abstract] [Full Text] [Related]

  • 16. Interferon-beta(1b) treatment in neuromyelitis optica.
    Tanaka M, Tanaka K, Komori M.
    Eur Neurol; 2009 Apr 16; 62(3):167-70. PubMed ID: 19590215
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis and treatment of neuromyelitis optica.
    Wingerchuk DM.
    Neurologist; 2007 Jan 16; 13(1):2-11. PubMed ID: 17215722
    [Abstract] [Full Text] [Related]

  • 18. [Neuromyelitis optica: the disease entity, pathogenesis and therapy].
    Fujihara K.
    Rinsho Shinkeigaku; 2007 Nov 16; 47(11):883-5. PubMed ID: 18210826
    [Abstract] [Full Text] [Related]

  • 19. CNS aquaporin-4 autoimmunity in children.
    McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, Kuntz NL, Fryer JP, Homburger H, Hunter J, Weinshenker BG, Krecke K, Lucchinetti CF, Pittock SJ.
    Neurology; 2008 Jul 08; 71(2):93-100. PubMed ID: 18509092
    [Abstract] [Full Text] [Related]

  • 20. Neuromyelitis optica and non organ-specific autoimmunity.
    Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zéphir H, Moder K, Weinshenker BG.
    Arch Neurol; 2008 Jan 08; 65(1):78-83. PubMed ID: 18195142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.